Jeon et al. demonstrated that the induction of ACTA2 through the dimerization of EGFR and HER2 is regulated by a JAK2/STAT1 signaling pathway and that abnormal expression of ACTA2 increases the invasiveness and metastasis of breast cancer cells [17]. Here, ERBB2 is linked to breast carcinoma.